E

Eurostars

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

Eurostars is a prominent European joint programme dedicated to stimulating research and development (R&D) performing small and medium-sized enterprises (SMEs). Operating under the umbrella of the Eureka network, Eurostars provides grants, rather than traditional venture capital equity investments, to foster international collaborative R&D and innovation projects. The programme is 'bottom-up,' meaning it has no thematic restrictions, allowing SMEs from various sectors to apply for funding for their innovative ideas.

This funding mechanism is designed to support market-driven R&D projects that lead to new products, processes, or services. Projects must involve at least two participants from two different Eurostars countries, with R&D-performing SMEs playing a central role. The programme aims to accelerate the commercialization of innovative solutions by providing financial support for the critical R&D phase, thereby reducing the financial burden on SMEs and encouraging cross-border collaboration.

Funding for Eurostars projects is provided by national funding bodies within participating countries, which means the exact grant amounts and funding rates can vary. However, the programme provides general guidelines and averages. The average grant awarded per project is approximately €370,000, equivalent to about $399,600 USD. The typical maximum funding per project can reach around €500,000, or approximately $540,000 USD, though this is subject to national variations. While there isn't a universally stated minimum grant, typical projects receiving Eurostars support are substantial, suggesting that the smallest typical grant would be a significant sum to support international R&D efforts.

Eurostars plays a crucial role in the European innovation ecosystem by enabling SMEs to overcome financial hurdles and access international expertise. Its focus on grants rather than equity allows companies to retain full ownership of their intellectual property, making it an attractive funding option for R&D-intensive businesses looking to scale their innovations globally. The programme has supported thousands of projects, contributing significantly to technological advancements and economic growth across Europe.

Investor Profile

Eurostars has backed more than 100 startups, with 8 new investments in the last 12 months alone. The firm has led 69 rounds, about 69% of its total and boasts 7 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Series Unknown, Seed rounds (top funding stages).
  • Majority of deals are located in Switzerland, Lithuania, The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 8 rounds in the past year.
  • Typical check size: $162K – $540K.

Stage Focus

  • Grant (96%)
  • Series Unknown (1%)
  • Seed (1%)
  • Series A (1%)
  • Pre Seed (1%)

Country Focus

  • Switzerland (34%)
  • Lithuania (15%)
  • The Netherlands (10%)
  • Sweden (8%)
  • United Kingdom (7%)
  • Spain (4%)
  • Denmark (4%)
  • France (4%)
  • Germany (4%)
  • United States (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Manufacturing
  • Life Science
  • Medical Device
  • Pharmaceutical
  • Software
  • Artificial Intelligence (Ai)
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eurostars frequently co-invest with?

MT
Europe, Cantabria, Spain, Santander
Co-Investments: 1
EASME - EU Executive Agency for SMEs
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
Innovate UK
Europe, Wiltshire, United Kingdom, Swindon
Co-Investments: 1
GENESIS Ventures
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
VI
Europe, Comunidad Valenciana, Spain, Valencia
Co-Investments: 1
H2
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
US Department of Energy
North America, District of Columbia, United States, Washington
Co-Investments: 1
Innosuisse
Europe, Bern, Switzerland, Berne
Co-Investments: 3
Co-Investments: 2

What are some of recent deals done by Eurostars?

Broken String Biosciences

Cambridge, Cambridgeshire, United Kingdom

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

BiotechnologyHealth Care
GrantJul 10, 2025
Cellevate

Lund, Skane Lan, Sweden

Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

Biotechnology
GrantApr 25, 2025
OLS OMNI Life Science

Bremen, Bremen, Germany

OLS OMNI Life Science provides solutions in 3D cell culture, cell counting, cell assays, cell imaging, and microbiology.

BiotechnologyGeneticsMedicalSmall and Medium Businesses
GrantApr 25, 2025
Verigraft AB

Gothenburg, Vastra Gotaland, Sweden

Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine.

BiotechnologyLife ScienceMedicalMedical Device
GrantFeb 13, 2025
Amount Raised: $1,249,633
Bomill AB

Vintrie, Skane Lan, Sweden

Bomill AB is develops and markets equipment for analysis and separation of grain and other granular products in the food industry.

AgricultureConsumer GoodsFarmingFood and BeverageMachinery ManufacturingManufacturing
GrantFeb 10, 2025
Amount Raised: $458,093
LipUm

Umeå, Vasterbottens Lan, Sweden

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

BiotechnologyHealth CarePharmaceuticalTherapeutics
GrantDec 17, 2024
Age Labs

Oslo, Oslo, Norway

Age Labs is a molecular diagnostics company focused on reducing the cost of developing drugs by accurately measuring your biological age.

BiotechnologyHealth Care
GrantDec 17, 2024
NOVIGENIX

Epalinges, Vaud, Switzerland

Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsLife ScienceMachine LearningPrecision MedicinePredictive Analytics
GrantSep 24, 2024
Amount Raised: $1,800,000
ProVascTec

Cork, Cork, Ireland

ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.

BiotechnologyTherapeutics
GrantAug 22, 2024
Amount Raised: $2,334,329
Correntics

Zürich, Zurich, Switzerland

Reimagining the future: Empowering organizations to weather the storm and thrive.

Risk ManagementSoftwareSupply Chain ManagementSustainability
GrantMay 14, 2024
Amount Raised: $1,622,085